In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have been sliding down over the past few years due to waning demand for the ...

If you’re in a group being offered the vaccine you will likely get a text reminder from the NHS. Pfizer's Comirnaty and Moderna's Spikevax vaccines are currently the 2 types of vaccines offered in the ...

Moderna is still generating decent sales from its COVID-19 vaccine. The biotech has won important clinical and regulatory approvals this year. Moderna's portfolio should look much stronger in a ...

Moderna, a leader in mRNA medicine, developed one of the earliest COVID-19 vaccines, with Spikevax being its first commercial product. The company's mRNA platform enables the development of ...

Estas cifras, proporcionadas por el Servicio de Información Agroalimentaria y Pesquera (SIAP), destacan el potencial de la vainilla mexicana en el mercado global. ¿Por qué agregan esta fecha al ...

Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement linked to the development of the first Covid-19 vaccines. The US biotech company is alleging that mRNA ...